recurrent ovarian epithelial cancer
Showing 1 - 25 of 43
Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)
Suspended
- Brenner Tumor
- +27 more
- metformin hydrochloride
- +2 more
-
Birmingham, Alabama
- +9 more
May 16, 2022
Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Duarte, Pasadena
Active, not recruiting
- Fallopian Tube Cancer
- +2 more
-
Duarte, California
- +1 more
Mar 17, 2022
Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in
Completed
- Recurrent Fallopian Tube Cancer
- +23 more
- ALVAC(2)-NY-ESO-1 (M)/TRICOM vaccine
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Mar 25, 2020
Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer Trial in
Completed
- Recurrent Fallopian Tube Cancer
- +2 more
- auranofin
- laboratory biomarker analysis
-
Rochester, MinnesotaMayo Clinic
Jul 31, 2019
Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (tamoxifen
Completed
- Fallopian Tube Cancer
- +4 more
- tamoxifen citrate
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (bortezomib, laboratory biomarker
Completed
- Primary Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer
- bortezomib
- +2 more
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (lapatinib ditosylate, laboratory
Completed
- Primary Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer
- lapatinib ditosylate
- laboratory biomarker analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer Trial in Philadelphia
Completed
- Primary Peritoneal Cavity Cancer
- +2 more
- bevacizumab
- laboratory biomarker analysis
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (ixabepilone)
Completed
- Primary Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (irofulven)
Completed
- Primary Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (everolimus,
Completed
- Fallopian Tube Cancer
- +2 more
- everolimus
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 9, 2019
Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,
Completed
- Fallopian Tube Cancer
- +10 more
- denileukin diftitox
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
May 13, 2019
Fallopian Tube Cancer, Malignant Tumor of Peritoneum, Recurrent Ovarian Epithelial Cancer Trial in Houston, Charlottesville
Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma, Recurrent Fallopian Tube Cancer Trial in Philadelphia
Withdrawn
- Ovarian Papillary Serous Carcinoma
- +5 more
- metformin hydrochloride
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Feb 18, 2019
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute
Terminated
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
- +13 more
- ipilimumab
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 4, 2018
Advanced Malignant Mesothelioma, Carcinoma of the Appendix, Ovarian Sarcoma Trial in Winston-Salem (HIPEC Orientation,
Completed
- Advanced Malignant Mesothelioma
- +15 more
- HIPEC Orientation
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 2, 2018
Recurrent Ovarian Epithelial Cancer, Recurrent Fallopian Tube Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in Duarte
Completed
- Recurrent Ovarian Epithelial Cancer
- +2 more
- modified vaccinia virus ankara vaccine expressing p53
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 26, 2018
Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Seattle (biological, drug, other)
Completed
- Brenner Tumor
- +11 more
- sargramostim
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Jul 24, 2017
Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Malignant Tumor of Peritoneum Trial in Stanford
Terminated
- Recurrent Ovarian Epithelial Cancer
- +4 more
- stereotactic body radiation therapy
- +4 more
-
Stanford, CaliforniaStanford University
Apr 26, 2017
Fallopian Tube Cancer, Female Reproductive Cancer, Recurrent Breast Cancer Trial in United States (ixabepilone, pegylated
Completed
- Fallopian Tube Cancer
- +6 more
- ixabepilone
- pegylated liposomal doxorubicin hydrochloride
-
Farmington, Connecticut
- +4 more
Feb 11, 2016
Recurrent Ovarian Epithelial Cancer Trial in Bronx, New York (oxaliplatin, topotecan)
Terminated
- Recurrent Ovarian Epithelial Cancer
-
Bronx, New York
- +1 more
Oct 27, 2015
Anxiety Disorder, Depression, Fatigue Trial in Columbus (other, procedure, behavioral)
Completed
- Anxiety Disorder
- +19 more
- questionnaire administration
- +5 more
-
Columbus, OhioOhio State University Medical Center
Oct 8, 2015
HER2-positive Breast Cancer, Recurrent Breast Cancer, Recurrent NSCLC Trial in Seattle (drug, biological, other)
Completed
- HER2-positive Breast Cancer
- +8 more
- ex vivo-expanded HER2-specific T cells
- +4 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Nov 7, 2014
Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIIA Ovarian Epithelial Cancer Trial in
Completed
- Recurrent Ovarian Epithelial Cancer
- +9 more
- cisplatin
- +2 more
-
Rochester, MinnesotaMayo Clinic
May 6, 2014